NCT05741710 - A Study to Assess the Use of Methylone in the Treatment of PTSD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

February 19, 2025

Study Completion Date

February 19, 2025

Conditions

Post Traumatic Stress Disorder

Interventions

DRUG

Methylone

Methylone capsules, given orally, once a week for 4 weeks

DRUG

Placebo

Placebo capsules to match methylone, given orally, once a week for 4 weeks. NOTE: Placebo is only in Part B

Trial Locations (16)

Sunstone Therapies, Rockville

Clinical Neuroscience Solutions - Jacksonville, Jacksonville

Accel Research Sites, Maitland

The Rivus Wellness & Research Institute, Oklahoma City

Mountain View Clinical Research, Denver

Cedar Clinical Research, Murray

Boston Clinical Trials, Boston

Cenexel HRI, Berlin

Tallaght Adult Mental Health Services, Dublin

La Nua Day Hospital Mental Health Centre, Galway

Mirabilis Health, Belfast

Cambridge University Hospitals NHS Foundation Trust, Cambridge

Glasgow Clinical Research Facility, QEUH, Glasgow

Clerkenwell Health, London

King's College, London

Oxford Health NHS Foundation Trust, Oxford